Articles

fibrin, MSCs, stem cells, heart failure, Antoni Bayes-Genis, umbilical cord

To date, the only definitive treatment for heart failure – an organ transplant – is hampered by both the limited number of organ donors and the potential for the patient’s body to reject the new...

cardiomems, st. jude medical, heart failure

Important new data presented during the Heart Rhythm Society's (HRS) 36th annual Scientific Session supporting improved outcomes and cost-effectiveness of the CardioMEMS HF System for the...

The buzz term “big data” has made a rapid entry onto the healthcare scene in the past couple years with promises of improving healthcare, but there are still many who are trying to figure out how...

heart regeneration, zebrafish, epicardium, Duke, Poss

While the human heart can’t heal itself, the zebrafish heart can easily replace cells lost by damage or disease. Now, researchers have discovered properties of a mysterious outer layer of the...

gene therapy, stem cells, heart failure, mutations, Mount Sinai, Hajjar

Gene therapy can clip out genetic material linked to heart failure and replace it with normal genes, according to a study from the Cardiovascular Research Center at Icahn School of Medicine at...

3D printing, 3-D printing

Several futuristic technologies and their potential impact on healthcare were discussed during the Future of Cardiovascular Medicine track sessions at the American College of Cardiology (ACC) 2015...

ivabradine (Corlanor)

The U.S. Food and Drug Administration (FDA) approved Amgen’s ivabradine (Corlanor) to reduce hospitalization from worsening heart failure.

Transmyocardial laser revascularization (TMLR or TMR) was introduced in the late 1990s as a method to offer relief to patients with incapacitating angina that were poor candidates for other...

catheter ablation, Afib, Amiodarone, Luigi Di Biase, ACC, heart failure

Patients with heart failure and atrial fibrillation were less likely to experience death, hospitalization or recurrent Afib with catheter ablation than with a heart rhythm-regulating drug,...

Bendavia, heart attack, scarring, angioplasty, ACC, study

Patients who received the new drug Bendavia before undergoing angioplasty or stent implantation after a heart attack showed no significant reduction in scarring compared to patients given a...